Scientific evidence for the use of current traditional systemic therapies in patients with hidradenitis suppurativa.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26470615.
- Also identified by DOI 10.1016/j.jaad.2015.07.049.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Traditional systemic therapies are frequently prescribed for the treatment of hidradenitis suppurativa (HS). Clinicians consider antibiotics, retinoids, antiandrogens, immunosuppressants, and less common treatment, such as fumarates, in the management of HS. Different classes of medications have been selected to treat HS based on their ability to target various pathways of the condition. Concerns about infection, such as infection with Clostridium difficile, necessitates switching therapy or shortening the course of therapy with specific antibiotics. This review explores the outcomes with the use of numerous medical therapies and postulates explanations for their efficacy or lack of response. Data on long-term safety and efficacy with traditional systemic therapies are lacking.
Medical subject headings
- Androgen Antagonists
- Anti-Bacterial Agents
- Hidradenitis Suppurativa
- Immunosuppressive Agents
- Retinoids